<DOC>
	<DOCNO>NCT00679731</DOCNO>
	<brief_summary>This study conduct compare efficacy ABT-874 versus Methotrexate subject moderate severe plaque psoriasis .</brief_summary>
	<brief_title>A Study Safety Efficacy Comparing ABT-874 Versus Methotrexate Subjects With Moderate Severe Plaque Psoriasis</brief_title>
	<detailed_description>This study conduct EU Canada</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Diagnosis Psoriasis 6 MO.. BSA 10 % , PASI 12 , PGA 3 Previous exposure antiIL 12</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Psoriasis</keyword>
</DOC>